AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden · Delayed Price · Currency is SEK 1.470
-0.005 (-0.34%)
Apr 10, 2026, 5:09 PM CET
AlzeCure Pharma AB Market Cap
AlzeCure Pharma AB has a market cap or net worth of 169.5 million as of April 10, 2026. Its market cap has decreased by -30.45% in one year.
Market Cap
169.50M
Enterprise Value
121.72M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.47
Market Cap Chart
Since November 28, 2018, AlzeCure Pharma AB's market cap has decreased from 415.42M to 169.50M, a decrease of -59.20%. That is a compound annual growth rate of -11.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 171.22M | -25.50% |
| Dec 30, 2025 | 229.83M | 126.34% |
| Dec 30, 2024 | 101.54M | -47.41% |
| Dec 29, 2023 | 193.09M | -24.88% |
| Dec 30, 2022 | 257.04M | 14.39% |
| Dec 30, 2021 | 224.71M | -34.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 263.55M |
| Mendus AB | 261.96M |
| Diamyd Medical AB | 256.65M |
| Xintela AB | 235.13M |
| Initiator Pharma | 224.53M |
| Isofol Medical AB | 182.72M |
| Active Biotech AB | 155.53M |
| Xbrane Biopharma AB | 145.06M |